|Alma mater||University of Tehran |
Massachusetts Institute of Technology (PhD)
Leila Pirhaji is an Iranian scientist and entrepreneur. She is the founder and CEO of the biotech start-up ReviveMed, which raised $1.5 million in 2018. ReviveMed analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.
Early life and education[edit | edit source]
Pirhaji earned a Bachelor's degree in Biotechnology from the University of Tehran in 2008 and a Master's degree in 2010. She began working on metabolomics during her doctoral studies at the Massachusetts Institute of Technology (MIT). She studied the interactions between proteins and metabolites. During her PhD, she worked as an intern at Merck & Co. She recognised that machine learning could be useful to analyse these interactions. Together with her advisor Ernest Fraenkel, Pirhaji founded ReviveMed. She completed her PhD at MIT in 2016,
Career and research[edit | edit source]
ReviveMed[edit | edit source]
ReviveMed can distinguish similar mass metabolites and correlate them to drugs, protein effects and the outcomes of disease. The company translates data from metabolites into therapeutic solutions. She is working on untreatable diseases which have shown a good chance of treatment. Pirhaji is one of the first to use large-scale metabolomic data to treat these diseases. She secured $1.5 million in a seed round in 2018 and $200,000 at a Google machine learning competition. She became Chief Executive Officer in 2017. Their technology was published in Nature Methods. ReviveMed won the BioTech Award at the ExtremeTech Challenge 2018.
Views[edit | edit source]
References[edit | edit source]
- Leila Pirhaji publications indexed by Google Scholar
- Pirhaji, Leila (2016). Revealing disease-associated pathways and components by systematic integration of large-scale biological data. dspace.mit.edu (PhD thesis). MIT. hdl:1721.1/104227. OCLC 958142368.
- Coldewey, Devin (2018-04-18). "ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it". TechCrunch.com. Retrieved 2018-07-30.
- "Bloomberg Executive Profile". bloomberg.com. Bloomberg. Retrieved 2018-07-30.
- "ReviveMed team won $10K Booz Allen Hamilton analytics prize of MIT $100K competition, awarded to the most innovative analytic solution in businesses". revive-med.com. ReviveMed Technologies. 2016-05-12. Retrieved 2018-07-30.
- Murphy, Meg (2016-06-02). "At MIT, a culture of innovation 'never gets old'". MIT News. Retrieved 2018-07-30.
- "ReviveMed was selected as a top 26 winners of MassChallenge Boston 2017. - ReviveMed Technologies". ReviveMed Technologies. 2017-10-05. Retrieved 2018-07-30.
- "Leila Pirhaji ReviveMed - PMWC Precision Medicine World Conference". PMWC Precision Medicine World Conference. Retrieved 2018-07-30.
- Khosravi, Bijan (2018-03-08). "How Persian Women Entrepreneurs Are Changing The Tech Industry". Forbes. Retrieved 2018-07-30.
- Pirhaji, Leila; Milani, Pamela; Leidl, Mathias; Curran, Timothy; Avila-Pacheco, Julian; Clish, Clary B; White, Forest M; Saghatelian, Alan; Fraenkel, Ernest (2016). "Revealing disease-associated pathways by network integration of untargeted metabolomics". Nature Methods. 13 (9): 770–776. doi:10.1038/nmeth.3940. ISSN 1548-7091. PMC 5209295. PMID 27479327.
- "ReviveMed is the BioTech Winner of Extreme Tech Challenge 2018. - ReviveMed Technologies". ReviveMed Technologies. 2018-01-12. Retrieved 2018-07-30.
- Stendahl, Max (2017-01-31). "Iranian MIT grad and biotech CEO fears for future after Trump ban". bizjournals.com. Retrieved 2018-07-30.
This article "Leila Pirhaji" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Leila Pirhaji. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.